United Services Automobile Association Eagle Pharmaceuticals, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$53.25 - $59.98 $393,943 - $443,732	-7,398 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $31,028 - $57,231	845 Added 12.89%	7,398 $298,000
Q3 2018 Nov 13, 2018	SELL	$66.65 - $83.86 $315,921 - $397,496	-4,740 Reduced 41.97%	6,553 $454,000
Q1 2018 May 14, 2018	BUY	$52.16 - $66.86 $79,439 - $101,827	1,523 Added 15.59%	11,293 $595,000
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $455,477 - $589,717	9,770	9,770 $583,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.